GEMONIL Drug Patent Profile
✉ Email this page to a colleague
When do Gemonil patents expire, and when can generic versions of Gemonil launch?
Gemonil is a drug marketed by Abbvie and is included in one NDA.
The generic ingredient in GEMONIL is metharbital. Additional details are available on the metharbital profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for GEMONIL?
- What are the global sales for GEMONIL?
- What is Average Wholesale Price for GEMONIL?
Summary for GEMONIL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 32 |
| Patent Applications: | 2,350 |
| DailyMed Link: | GEMONIL at DailyMed |
US Patents and Regulatory Information for GEMONIL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abbvie | GEMONIL | metharbital | TABLET;ORAL | 008322-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
